COLLEGIUM PHARMACEUTICAL, INC (COLL)
$25.35-$1.09 (-4.12%) Today
Scott Dreyer - OfficerScott Dreyer - OfficerCollegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
https://www.collegiumpharma.comSEC filings for COLL on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 2 | 17,400 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
38 Form 4 filings on record, the earliest from Nov 14, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Carlos V. Paya - Director | Grant or award | Common Stock | 19,582 | $0.00 | - | |
| Gino Santini - Director | Grant or award | Common Stock | 9,791 | $0.00 | - | |
| John Gordon Freund - Director | Grant or award | Common Stock | 9,791 | $0.00 | - | |
| Rita J. Balice-Gordon - Director | Grant or award | Common Stock | 9,791 | $0.00 | - | |
| John A. Fallon - Director | Grant or award | Common Stock | 9,791 | $0.00 | - | |
| Nancy Lurker - Director | Grant or award | Common Stock | 9,791 | $0.00 | - | |
| Garen G. Bohlin - Director | Grant or award | Common Stock | 9,791 | $0.00 | - | |
| Vikram Karnani - Officer | Grant or award | Common Stock | 105,972 | $0.00 | - | |
| Vikram Karnani - Officer | Grant or award | Stock Option (Right to Purchase) | 130,344 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 38 COLL filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
COLLEGIUM PHARMACEUTICAL, INC (COLL) had 1 insider filing in the last 90 days, with the most recent on 2026-06-10. The full record for COLL runs to 38 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of COLL were filed in the last 90 days.
No insider sales of COLL were filed in the last 90 days. 18 sales are on record for this company.
This page tracks COLL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add COLL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$COOCOOPER COMPANIES, INC.
$CORTCORCEPT THERAPEUTICS INC
$COYACoya Therapeutics, Inc.
$CPIXCUMBERLAND PHARMACEUTICALS INC
$CPRXCATALYST PHARMACEUTICALS, INC.
$CRBPCorbus Pharmaceuticals Holdings, Inc.
$CRDFCardiff Oncology, Inc.
$CRGXCARGO Therapeutics, Inc.
$CRISCURIS INC
$CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
